Human BCMA (CD269) Recombinant
$160.00 – $3,300.00
| accession | Q02223 |
| Source | Optimized DNA sequence encoding Human BCMA extracellular domain sp|Q02223|1-54 fused to C terminal Human IgG1 Fc His tag was expressed in HEK293 Cells. |
| Molecular weight | Recombinant BCMA (CD269) Fc chimera is a homodimer protein consisting of 300 amino acid residue subunits,and migrates as an approximately 80kDa band under non-reducing and ask 40Da band under reducing conditions in SDS-PAGE. |
| Purity | >95%, as determined by SDS-PAGE and HPLC |
| Biological Activity | The ED(50) was determined by the ability to bind immobilized recombinant Human BAFF and was calculated to beng/ml . |
| Protein Sequence | MLQMAGQCSQ NEYFDSLLHA CIPCQLRCSS NTPPLTCQRY CNASVTNSVK GTNA ILWTCL |
| Endotoxin | Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than.1 ng/µg(1EU/µg). |
| Presentation | Recombinant BCMA was lyophilized from a.2 μm filteredmm Tris solutionpH.5. |
| Reconstitution | A quick spin of the vial followed by reconstitution in distilled water to a concentration not less than.1 mg/mL. This solution can then be diluted into other buffers. |
| Storage | The lyophilized protein is stable for at least years from date of receipt at -20° C. Upon reconstitution, this product can be stored in working aliquots at° -° C for one month, or at -20° C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles. |
| Usage | This product is for research purposes only.It may not be used for therapeutics or diagnostic purposes. |
| Biological Process | Immunity |
| Molecular function | Receptor |